4 days ago
Psychiatric Drugs Relieve Symptoms but Can Become a Burden
The article looks at how psychiatric hospitals and medicines affect people with serious mental illnesses.
Medicines can make frightening experiences such as hallucinations and delusions go away.
However, some patients may then feel numb, tired, unhappy or unable to do everyday activities.
One patient, called Rahul, felt better after changing to Aripiprazole.
His symptoms later returned, so doctors used Risperidone again along with a higher dose of Aripiprazole.
The article says doctors and patients can disagree about whether tiredness comes from the illness or the medicine.
It also describes hospitals as restrictive and boring places for some patients.
The author believes medicines are still important but says their burdens and long-term use need more careful attention.
Patients in a psychiatric ward included people with autism, psychosis, depression, addiction, dementia and schizophrenia.
The article says Risperidone and Paliperidone quickly reduced hallucinations and delusions but could cause dysphoria, apathy, emotional numbness, lethargy and weight gain.
A patient identified as Rahul experienced fewer side effects after switching to Aripiprazole, though his symptoms later returned and Risperidone was reintroduced.
The author argues doctors sometimes attribute tiredness and lethargy to illness-related “negative symptoms” rather than medication effects.
The article says medication is currently viewed as the main route to psychological freedom, while the timing of safely stopping treatment remains uncertain.
- Who
- The article’s author, freelance journalist Dhruv Ramnath, psychiatric patients including Rahul, doctors and pharmaceutical companies.
- What
- An examination of psychiatric hospitalization and the benefits, side effects and uncertain long-term use of antipsychotic medicines.
- Where
- A psychiatric ward in India; the article also discusses India’s pharmaceutical industry.
- When
- The author describes months of research and fieldwork, while Rahul’s account includes seven years of trying different medicines and ongoing monthly treatment.
- Why
- The article seeks to question whether treatments that suppress symptoms can also reshape patients’ emotions, energy and daily lives.
Treatment benefits and medical necessity
Treatment burdens and patient concerns
Role of medication
Treatment benefits and medical necessity
Antipsychotic medicines can quickly suppress hallucinations and delusions, and the article presents medication as the current route to psychological freedom for severe illness.
Treatment burdens and patient concerns
The author argues that the system treats drugs as the only route to recovery and may overlook how medicines themselves affect patients’ lives.
Causes of lethargy and emotional numbness
Treatment benefits and medical necessity
Doctors may interpret tiredness and inactivity as “negative symptoms” of the illness and prioritize keeping symptoms under control.
Treatment burdens and patient concerns
Patients and some empathetic doctors cited in the article believe the drugs can cause lethargy, emotional blunting and other debilitating effects.
Stopping long-term medication
Treatment benefits and medical necessity
Psychiatrists may hesitate to stop treatment because they must prevent hallucinations, delusions and other symptoms from returning.
Treatment burdens and patient concerns
The article says patients face uncertainty about when medication can safely end and may be left dealing with lasting effects after years of treatment.
Key facts
- Medicines discussed
- Risperidone, Paliperidone and Aripiprazole
- Reported benefits
- Risperidone and Paliperidone were described as rapidly reducing hallucinations and delusions.
- Reported burdens
- The article associates some treatments with dysphoria, apathy, emotional numbing, inertia, lethargy and weight gain.
- Patient example
- Rahul said Aripiprazole helped him exercise and feel emotions again, but his symptoms later returned.
- Treatment change
- Rahul was placed back on Risperidone, while his Aripiprazole dose was increased.
- Ongoing treatment
- Rahul receives a monthly Paliperidone injection and uses Aripiprazole to mitigate its effects, according to the article.
- Industry figure
- The article states that pharmaceutical companies in India earn Rs 60 billion annually.
Sources
Related news
The dark side of India's booming market for weight-loss drugs
DRI busts illegal drug manufacturing facility in Maharashtra
From Custody To Care: India's Mental Health Evolution Since 1947
Nupoor Mohan’s Full Circle Targets India’s Mental Healthcare Gap
Ex-UK Doctor Praises India's Easy Late-Night Medicine Access
